Cited 0 time in
Impact of adherence to anti-hypertensive drugs after acute ischemic stroke
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jung, S. | - |
| dc.contributor.author | Ki-Jong, P. | - |
| dc.contributor.author | Changhyo, Y. | - |
| dc.date.accessioned | 2024-12-03T05:30:46Z | - |
| dc.date.available | 2024-12-03T05:30:46Z | - |
| dc.date.issued | 2019-10 | - |
| dc.identifier.issn | 0022-510X | - |
| dc.identifier.issn | 1878-5883 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/74392 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Impact of adherence to anti-hypertensive drugs after acute ischemic stroke | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.jns.2019.10.554 | - |
| dc.identifier.wosid | 000516770701643 | - |
| dc.identifier.bibliographicCitation | Journal of the Neurological Sciences, v.405 | - |
| dc.citation.title | Journal of the Neurological Sciences | - |
| dc.citation.volume | 405 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
